MXC Q3 2025 Earnings Positive EPS of 022 Amid Quiet Quarter EXAS Q4 2025 Earnings Significant EPS Miss Amidst Challenging Quarter RLI Q1 2026 Earnings EPS Beats by Nearly 5 as Underwriting Disciplines Deliver BWBBP Q1 2026 Earnings Preferred Stock EPS Slightly Misses Estimates Stock Declines Modestly Werewolf Therapeutics HOWL Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline CRGO Q1 2026 Earnings EPS Misses Estimates by Nearly 70 No Revenue Reported Stock Slides 574